MARKET

VRAY

VRAY

ViewRay
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.54
-0.07
-1.06%
After Hours: 6.53 -0.01 -0.15% 17:03 09/17 EDT
OPEN
6.65
PREV CLOSE
6.61
HIGH
6.72
LOW
6.46
VOLUME
2.18M
TURNOVER
--
52 WEEK HIGH
7.36
52 WEEK LOW
2.750
MARKET CAP
1.07B
P/E (TTM)
-9.0381
1D
5D
1M
3M
1Y
5Y
ViewRay® to Partcipate in the Cantor Global Healthcare Conference
/PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will participate in the Cantor Global Healthcare Conference. , President and Chief Executive Officer, and , Chief Financial Officer, will participate in a fireside chat at , Sept...
PR Newswire - PRF · 1d ago
8 Health Care Stocks With Unusual Options Alerts In Today's Session
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. Unusual trading activity could push option price...
Benzinga · 09/10 17:39
Return on Capital Employed Overview: ViewRay
After pulling data from Benzinga Pro it seems like during Q2, ViewRay (NASDAQ:VRAY) brought in sales totaling $15.03 million. However, earnings decreased 7.34%, resulting in a loss of $26.48 million.
Benzinga · 08/27 21:14
ViewRay® to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
/PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will present at the Morgan Stanley 19 Annual Global Healthcare Conference. , President and Chief Executive Officer, and , Chief Financial Officer, will participate in a fireside ...
PR Newswire - PRF · 08/27 20:01
ASND, GDS, ADSK and CDZI among after hours movers
Gainers: ASND +22.8%. GDS +7.0%. CD +5.6%. ULTA +5.4%. VRAY +4.7%. Losers: ADSK -6.8%. CDZI -5.3%. GNLN -4.7%. ACET -4.6%. AVNW -4.4%.
Seekingalpha · 08/25 21:38
Viewray Inc (VRAY) CFO Zachary William Stassen Bought $212,800 of Shares
GuruFocus News · 08/25 10:58
ViewRay Announces Amsterdam University Medical Centers Has Begun Using MRIdian SMART
ViewRay, Inc. (NASDAQ:VRAY) today announced that the clinical team at Amsterdam University Medical Centers (Amsterdam UMC) has started offering "same-day ablative treatment" using MRIdian SMART
Benzinga · 08/24 10:33
Amsterdam University Medical Centers establishes same-day ablative treatment service using MRIdian® to Streamline the Patient Experience.
/PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced that the clinical team at Amsterdam University Medical Centers (Amsterdam UMC) has started offering "same-day ablative treatment" using MRIdian SMART (stereotactic MR-guided adaptive radiotherapy...
PR Newswire - PRF · 08/24 10:30
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of VRAY. Analyze the recent business situations of ViewRay through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average VRAY stock price target is 8.00 with a high estimate of 9.00 and a low estimate of 7.00.
EPS
Institutional Holdings
Institutions: 232
Institutional Holdings: 197.47M
% Owned: 120.17%
Shares Outstanding: 164.32M
TypeInstitutionsShares
Increased
60
11.51M
New
29
2.05M
Decreased
30
7.01M
Sold Out
15
2.43M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.54%
Healthcare Equipment & Supplies
+0.65%
Key Executives
Non-Executive Chairman/Independent Director
Daniel Moore
President/Chief Executive Officer/Director
Scott Drake
Chief Financial Officer
Zachary Stassen
Chief Scientific Officer
James Dempsey
Director
Karen Prange
Independent Director
Caley Castelein
Independent Director
B. Kristine Johnson
Independent Director
Brian Roberts
Independent Director
Phillip Spencer
Independent Director
Gail Wilensky
Independent Director
Kevin Xie
No Data
About VRAY
ViewRay Inc. designs, manufactures and markets the ViewRay MRIdian. The MRIdian is a system that integrates high quality radiation therapy with simultaneous magnetic resonance imaging (MRI). It provides two generations of the MRIdian: the first generation MRIdian with Cobalt-60 based radiation beams and the second generation MRIdian Linac, with linear accelerator (linac) based radiation beams. The MRIdian combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients. MRIdian also records the level of radiation dose that the treatment area has received. MRIdian system is comprised of three components: the MRI system, the radiation delivery system and an integrated treatment planning and delivery software. The MRI system is the component of MRIdian that captures soft tissue images of the patient’s body. Its MRI system captures and displays live images in one plane, four times per second or in three planes, two times per second.

Webull offers kinds of Viewray Inc stock information, including NASDAQ:VRAY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VRAY stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading VRAY stock methods without spending real money on the virtual paper trading platform.